Adoptive Cell Therapy for Metastatic Cancer
P
Peter Attia MD hosts a discussion with Steve Rosenberg.
ImmunityMedical
Story of claim
Adoptive cell therapy involves engineering lymphocytes to target and potentially cure metastatic cancers by modifying receptor sequences like p53.
- Goal: To engineer lymphocytes to target and cure metastatic cancers.
- Proof: Engineering lymphocytes with known receptor sequences allows targeting and regression of metastatic cancers.
- Nuances:
- Genetic modification of lymphocytes to target cancer
- Libraries of receptors against p53, kras isolated
- Impact on Life: Potential for curing metastatic cancers, though requiring significant medical intervention and monitoring.
Investments
- Price: Estimated $150,000 per treatment
- Time: Extensive, involves multiple hospital visits
- Effort: High effort due to complexity and ongoing medical care
Risks
Genetic modifications may lead to unforeseen immune reactions; requires extensive monitoring.
Alternatives
- Targeted drug therapies
- Experimental trials
Get Started 🚀
- Discuss adoptive cell therapy with a cancer specialist
- Evaluate eligibility based on cancer type and stage
- Understand genetic modification implications
Brogevity AI can make mistakes. Check important info.